NetWorth
LeaderPortfolio
Shanghvi
Dilip Shanghvi
Rank #99
INDIA•Healthcare•Pharmaceuticals

Dilip Shanghvi

Net Worth
$25.429B
+0.76% (24h)
Dilip Shanghvi, born in 1955, is an Indian billionaire businessman and the founder of Sun Pharmaceutical Industries, a leading global pharmaceutical company. His wealth stems from his strategic vision and leadership in the healthcare industry, building a company known for its quality and affordable medicines. Shanghvi's career began by assisting his father's wholesale medicine business, which inspired him to start his own pharmaceutical manufacturing enterprise. He has received numerous awards and recognitions for his achievements, including the Padma Shri. His current net worth is estimated to be $25.8 billion, reflecting his significant contributions to the pharmaceutical sector.

How to read Dilip Shanghvi's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Dilip Shanghvi, we anchor the narrative to Pharmaceuticals and Pharmaceuticals, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $25.429B alongside global rank #99, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (INDIA) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Dilip Shanghvi was born on October 1, 1955, in Amreli, Gujarat, India, into a Jain family. His father was a wholesale drug distributor. He studied at J. J. Ajmera High School and earned a Bachelor of Commerce degree from the University of Calcutta.

Rise to Success

In 1983, at the age of 27, Dilip Shanghvi founded Sun Pharmaceutical Industries with a small loan from his father. The company initially focused on manufacturing psychiatric drugs. Shanghvi's strategic approach, including acquiring other companies, fueled Sun Pharma's growth. The acquisition of Ranbaxy Laboratories in 2014 was a major milestone, making Sun Pharma the largest pharmaceutical company in India and among the top global generic drug makers. The company now has a strong global presence, operating in over 100 countries.

Key Business Strategies

Shanghvi's key business strategies include focusing on niche markets, organic growth, and strategic acquisitions. He is known for his emphasis on quality, affordability, and patient needs. This strategy has enabled Sun Pharma to become a leading specialty generic pharmaceutical company worldwide.

Philanthropy

Dilip Shanghvi is known for his philanthropic work and has donated to various educational and healthcare institutions. He is also a trustee of the Rhodes Scholarship Program at Oxford University and Chairman of the Shantilal Shanghvi Foundation.

Career Timeline

2016

Awarded Padma Shri

Received the Padma Shri, the fourth-highest civilian award in India.

2014

Acquired Ranbaxy Laboratories

Sun Pharma acquired Ranbaxy, becoming India's largest pharmaceutical company.

1994

Sun Pharma Listed on Stock Exchange

Sun Pharma went public, oversubscribed 55 times.

1983

Founded Sun Pharmaceutical Industries

Established Sun Pharma with a focus on psychiatric drugs.

Philanthropic Impact

Education and HealthcareUndisclosed

Shantilal Shanghvi Foundation

Supports education and healthcare initiatives.

EducationUndisclosed

Rhodes Scholarship Program at Oxford University

Serves as a trustee.

Key Business Ventures & Holdings

CompanyStakeValue
Sun Pharmaceutical Industries Ltd.54.48%—

Net Worth History

In-Depth Analysis

Early Life

Dilip Shanghvi was born on October 1, 1955, in Amreli, Gujarat, India, into a Jain family. His father was a wholesale drug distributor. He studied at J. J. Ajmera High School and earned a Bachelor of Commerce degree from the University of Calcutta.

Rise to Success

In 1983, at the age of 27, Dilip Shanghvi founded Sun Pharmaceutical Industries with a small loan from his father. The company initially focused on manufacturing psychiatric drugs. Shanghvi's strategic approach, including acquiring other companies, fueled Sun Pharma's growth. The acquisition of Ranbaxy Laboratories in 2014 was a major milestone, making Sun Pharma the largest pharmaceutical company in India and among the top global generic drug makers. The company now has a strong global presence, operating in over 100 countries.

Key Business Strategies

Shanghvi's key business strategies include focusing on niche markets, organic growth, and strategic acquisitions. He is known for his emphasis on quality, affordability, and patient needs. This strategy has enabled Sun Pharma to become a leading specialty generic pharmaceutical company worldwide.

Philanthropy

Dilip Shanghvi is known for his philanthropic work and has donated to various educational and healthcare institutions. He is also a trustee of the Rhodes Scholarship Program at Oxford University and Chairman of the Shantilal Shanghvi Foundation.

Data Sources & Methodology

Figures for Dilip Shanghvi are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.

You may also like

HubAll BillionairesHubGlobal RankingsHubNewsroom